{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:16:56Z","timestamp":1786375016883,"version":"build-2736575974"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,1]]},"DOI":"10.1093\/inthealth\/ihu058","type":"journal-article","created":{"date-parts":[[2014,8,31]],"date-time":"2014-08-31T00:43:56Z","timestamp":1409445836000},"page":"273-281","source":"Crossref","is-referenced-by-count":36,"title":["Management of Strongyloides stercoralis: a puzzling parasite"],"prefix":"10.1093","volume":"6","author":[{"given":"Viravarn","family":"Luvira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorn","family":"Watthanakulpanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punnee","family":"Pittisuttithum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,8,30]]},"reference":[{"key":"key\n\t\t\t\t20170203180243_IHU058C1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/CMR.17.1.208-217.2004","article-title":"Strongyloides stercoralis in the immunocompromised population","volume":"17","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20170203180243_IHU058C2","doi-asserted-by":"crossref","first-page":"e2288","DOI":"10.1371\/journal.pntd.0002288","article-title":"Strongyloides stercoralis: global distribution and risk factors","volume":"7","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C3","doi-asserted-by":"crossref","first-page":"545e1","DOI":"10.1016\/j.amjmed.2006.05.072","article-title":"Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey","volume":"120","year":"2007","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170203180243_IHU058C4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/qjmed\/hch133","article-title":"Chronic Strongyloides stercoralis infection in former British Far East prisoners of war","volume":"97","year":"2004","journal-title":"QJM."},{"key":"key\n\t\t\t\t20170203180243_IHU058C5","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1086\/314022","article-title":"Strongyloides-infected patients at Charleston area medical center, West Virginia, 1997\u20131998","volume":"31","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4269\/ajtmh.1982.31.313","article-title":"Epidemiologic features of Strongyloides stercoralis infection in an endemic area of the United States","volume":"31","year":"1982","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170203180243_IHU058C7","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/322707","article-title":"Diagnosis of Strongyloides stercoralis infection","volume":"33","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C8","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1517\/14656566.5.11.2293","article-title":"Treatment strategies in controlling strongyloidiasis","volume":"5","year":"2004","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"key\n\t\t\t\t20170203180243_IHU058C9","doi-asserted-by":"crossref","first-page":"e2002","DOI":"10.1371\/journal.pntd.0002002","article-title":"The laboratory diagnosis and follow up of strongyloidiasis: a systematic review","volume":"7","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C10","first-page":"631","article-title":"Agents active against parasites and pneumocytis","volume-title":"Mandell, Doughlas, and Bennett's Principles and Practice of Infectious Diseases","year":"2010","edition":"7th ed"},{"key":"key\n\t\t\t\t20170203180243_IHU058C11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.11150\/kansenshogakuzasshi1970.68.13","article-title":"Clinical study on ivermectin against 125 strongyloidiasis patients [in Japanese]","volume":"68","year":"1994","journal-title":"Kansenshogaku Zasshi"},{"key":"key\n\t\t\t\t20170203180243_IHU058C12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0035-9203(94)90110-4","article-title":"Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases","volume":"88","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20170203180243_IHU058C13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/infdis\/169.5.1076","article-title":"A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis","volume":"169","year":"1994","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C14","first-page":"147","article-title":"Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan","volume":"31","year":"2000","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"key\n\t\t\t\t20170203180243_IHU058C15","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1517\/14656566.5.12.2615","article-title":"Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis","volume":"5","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"key\n\t\t\t\t20170203180243_IHU058C16","doi-asserted-by":"crossref","first-page":"e1254","DOI":"10.1371\/journal.pntd.0001254","article-title":"Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis","volume":"5","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C17","doi-asserted-by":"crossref","first-page":"e1044","DOI":"10.1371\/journal.pntd.0001044","article-title":"Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis","volume":"5","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C18","first-page":"1515","article-title":"Soil-transmitted helminths (geohelminths)","volume-title":"Manson's Tropical Diseases","year":"2008","edition":"22nd ed"},{"key":"key\n\t\t\t\t20170203180243_IHU058C19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4269\/ajtmh.1996.55.477","article-title":"A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children","volume":"55","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170203180243_IHU058C20","first-page":"735","article-title":"A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis","volume":"26","year":"1995","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"key\n\t\t\t\t20170203180243_IHU058C21","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1086\/314023","article-title":"Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies","volume":"31","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0035-9203(82)90034-7","article-title":"Treatment of strongyloidiasis with thiabendazole: an analysis of toxicity and effectiveness","volume":"76","year":"1982","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20170203180243_IHU058C23","first-page":"479","article-title":"Strongyloides stercoralis and S. fulleborni","volume-title":"Principles and Practice","year":"2001","edition":"1st ed"},{"key":"key\n\t\t\t\t20170203180243_IHU058C24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.11150\/kansenshogakuzasshi1970.65.433","article-title":"Treatment of strongyloidiasis with mebendazole \u2013 long-term eradication and new trials [in Japanese]","volume":"65","year":"1991","journal-title":"Kansenshogaku Zasshi"},{"key":"key\n\t\t\t\t20170203180243_IHU058C25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2334-13-78","article-title":"Severe strongyloidiasis: a systematic review of case reports","volume":"13","year":"2013","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C26","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2169\/internalmedicine.39.695","article-title":"Strongyloidiasis \u2013 progress in diagnosis and treatment","volume":"39","year":"2000","journal-title":"Intern Med"},{"key":"key\n\t\t\t\t20170203180243_IHU058C27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11908-008-0019-6","article-title":"Strongyloides stercoralis infection in the immunocompromised host","volume":"10","year":"2008","journal-title":"Curr Infect Dis Rep"},{"key":"key\n\t\t\t\t20170203180243_IHU058C28","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1345\/aph.1K302","article-title":"Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection","volume":"41","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"7","key":"key\n\t\t\t\t20170203180243_IHU058C29","doi-asserted-by":"crossref","first-page":"e1581","DOI":"10.1371\/journal.pntd.0001581","article-title":"Is human immunodeficiency virus infection a risk factor for Strongyloides stercoralis hyperinfection and dissemination","volume":"6","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/422522","article-title":"Strongyloides stercoralis infection as a manifestation of immune restoration syndrome","volume":"39","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C31","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1086\/428099","article-title":"Strongyloidiasis in an HIV-1-infected patient after highly active antiretroviral therapy-induced immune restoration","volume":"191","year":"2005","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C32","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1258\/095646206778145712","article-title":"Dissemination of Strongyloides stercoralis as an immune restoration phenomenon in an HIV-1-infected man on antiretroviral therapy","volume":"17","year":"2006","journal-title":"Int J STD AIDS"},{"key":"key\n\t\t\t\t20170203180243_IHU058C33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/QAD.0b013e3280117f94","article-title":"Immune reconstitution syndrome to Strongyloides stercoralis infection","volume":"21","year":"2007","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170203180243_IHU058C34","first-page":"575470","article-title":"Central nervous system strongyloidiasis and cryptococcosis in an HIV-infected patient starting antiretroviral therapy","volume":"2012","year":"2012","journal-title":"Case Rep Med"},{"key":"key\n\t\t\t\t20170203180243_IHU058C35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jinf.2006.01.016","article-title":"Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review","volume":"54","year":"2007","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20170203180243_IHU058C36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(99)02744-0","article-title":"Parenteral ivermectin in Strongyloides hyperinfection","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170203180243_IHU058C37","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4269\/ajtmh.2005.73.911","article-title":"Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis","volume":"73","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170203180243_IHU058C38","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1086\/430827","article-title":"Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin","volume":"41","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C39","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4269\/ajtmh.2008.79.853","article-title":"Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection","volume":"79","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170203180243_IHU058C40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4269\/ajtmh.2005.73.122","article-title":"Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report","volume":"73","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170203180243_IHU058C41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ijantimicag.2013.07.015","article-title":"Strongyloides disseminated infection successfully treated with parenteral ivermectin: case report with drug concentration measurements and review of the literature","volume":"42","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170203180243_IHU058C42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4269\/ajtmh.2003.68.453","article-title":"Case report: rectal adminstration of ivermectin to a patient with Strongyloides hyperinfection syndrome","volume":"68","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170203180243_IHU058C43","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e3182115b7b","article-title":"Donor\u2013derived Strongyloides stercoralis infections in renal transplant recipients","volume":"91","year":"2011","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20170203180243_IHU058C44","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/630201","article-title":"Strongyloidiasis in transplant patients","volume":"49","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C45","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/QCO.0b013e3283551dbd","article-title":"Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis","volume":"25","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C46","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4269\/ajtmh.2002.66.749","article-title":"Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area","volume":"66","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170203180243_IHU058C47","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.trstmh.2005.12.006","article-title":"Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy","volume":"100","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20170203180243_IHU058C48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1201-9712(02)90132-3","article-title":"Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection","volume":"6","year":"2002","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C49","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"key\n\t\t\t\t20170203180243_IHU058C50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1399-3062.2009.00383.x","article-title":"Strongyloides hyperinfection syndrome and transplantation: a preventable, frequently fatal infection","volume":"11","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C51","first-page":"663","article-title":"Thiabendazole for the prophylaxis of strongyloidiasis in immunosuppressed patients with hematological diseases: a randomized double-blind placebo-controlled study","volume":"87","year":"2002","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20170203180243_IHU058C52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1258\/004947505774938558","article-title":"Comparison of albendazole regimen for prophylaxis of Strongyloides hyperinfection in nephrotic syndrome patients on long-term steroids in Cambodia","volume":"35","year":"2005","journal-title":"Trop Doct"},{"key":"key\n\t\t\t\t20170203180243_IHU058C53","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1017\/S0950268804003000","article-title":"The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States","volume":"132","year":"2004","journal-title":"Epidemiol Infect"},{"key":"key\n\t\t\t\t20170203180243_IHU058C54","first-page":"207","article-title":"Albendazole in the treatment of strongyloidiasis","volume":"18","year":"1987","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"key\n\t\t\t\t20170203180243_IHU058C55","first-page":"191","article-title":"Albendazole is effective treatment for chronic strongyloidiasis","volume":"86","year":"1993","journal-title":"QJM"},{"key":"key\n\t\t\t\t20170203180243_IHU058C56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijantimicag.2007.08.014","article-title":"Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis","volume":"31","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170203180243_IHU058C57","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1086\/375609","article-title":"Strongyloides stercoralis hyperinfection in a patient with AIDS in Uganda successfully treated with ivermectin","volume":"37","year":"2003","journal-title":"Clin Infec Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C58","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/1066896907302241","article-title":"Strongyloides hyperinfection in rheumatoid arthritis","volume":"15","year":"2007","journal-title":"Int J Surg Pathol"},{"key":"key\n\t\t\t\t20170203180243_IHU058C59","first-page":"818296","article-title":"Fatal outcome of disseminated strongyloidiasis despite detectable plasma and cerebrospinal levels of orally administered ivermectin","volume":"2009","year":"2009","journal-title":"J Parasitol Res"},{"key":"key\n\t\t\t\t20170203180243_IHU058C60","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4103\/0255-0857.71854","article-title":"Disseminated infection with Strongyloides stercoralis in a diabetic patient","volume":"28","year":"2010","journal-title":"Indian J Med Microbiol"},{"key":"key\n\t\t\t\t20170203180243_IHU058C61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijge.2011.01.010","article-title":"Acute respiratory distress syndrome complicating Strongyloides stercoralis","volume":"5","year":"2011","journal-title":"Int J Gerontol"},{"key":"key\n\t\t\t\t20170203180243_IHU058C62","doi-asserted-by":"crossref","first-page":"E139","DOI":"10.1111\/tid.12104","article-title":"Strongyloides stercoralis infection in an intestinal transplant recipient","volume":"15","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"key\n\t\t\t\t20170203180243_IHU058C63","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s15010-005-5060-x","article-title":"Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin","volume":"33","year":"2005","journal-title":"Infection"},{"key":"key\n\t\t\t\t20170203180243_IHU058C64","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00134-005-2725-y","article-title":"Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock","volume":"31","year":"2005","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t20170203180243_IHU058C65","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4269\/ajtmh.2010.10-0258","article-title":"Non\u2013oral treatment with ivermectin for disseminated strongyloidiasis","volume":"83","year":"2010","journal-title":"Am J Trop Med Hyg"}],"container-title":["International Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/inthealth\/article-pdf\/6\/4\/273\/9995056\/ihu058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T14:10:28Z","timestamp":1565791828000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/inthealth\/article-lookup\/doi\/10.1093\/inthealth\/ihu058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,30]]},"references-count":65,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,8,30]]},"published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/inthealth\/ihu058","relation":{},"ISSN":["1876-3413","1876-3405"],"issn-type":[{"value":"1876-3413","type":"print"},{"value":"1876-3405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,30]]}}}